TRIAL DETAIL
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors |
|||
NCT#: |
||||
Conditions: |
Solid Tumors |
|||
Status: |
Ongoing, but not recruiting |
|||
Phase: |
1 |
Start Date 06/01/2015 |
Age of Trial (yrs) 8.9 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
KIT/PDGFRA + PD-1 inhibitor |
|||
Strategy: |
||||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
PLX108-14 |
|||
Sponsor: |
Plexxikon |
|||
Patient Contact: |
Sandra Tong, M.D. (510) 647-4000 STong@plexxikon.com
Henry Hsu, M.D. (510) 647-4000 HHsu@plexxikon.com |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Oral
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
10945 Le Conte Ave. |
Los Angeles |
CA |
90095 |
USA |
|
1350 S Eliseo Dr # 100 |
Greenbrae |
CA |
94904 |
USA |
|
10460 N. 92nd St. |
Scottsdale |
AZ |
85258 |
USA |
|
4100 John R |
Detroit |
MI |
48201 |
USA |
|
1275 York Ave |
New York |
NY |
10065 |
USA |
|
4319 Medical Dr. |
San Antonio |
TX |
78229 |
USA |